comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 16:49:33 - browse：6

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Readout Newsletter: Biotech news, including Moderna's Covid vaccine

WSS

FDA authorizes Novavax’s updated Covid

Unique patient identifier: Experts argue the benefits, pitfalls

Johnson & Johnson sued for allegedly overpaying for workers' drugs

AI can decode, harness the power of the humane immune system

A virus, fished out of a lake, may have saved a man’s life

FDA rejects Alnylam's heart disease treatment over insufficient data

focus

comprehensive

leisure time

How to save PrEP access — and even expand it

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Bright Health sells Medicare Advantage business to Molina

340B reform proposal comes out of Senate working group

After affirmative action ruling, medical educators look to 'holistic review'

Surgery pushed Ben Carson to fame

Supreme Court strikes down use of affirmative action

Why Novartis is going to walk from its acquisition of MorphoSys

Cancer drug shortages should be causing more outrage

The future of health care in the House

Wikipedia

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

AI can decode, harness the power of the humane immune system

Liquid biopsy for lung cancer is launched by Delfi

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Padmanee Sharma of MD Anderson at center of lawsuit over credit

VC firm General Catalyst wants to buy a health system

Wikipedia

explore

focus

hotspot